Armistice Capital LLC Has $18.54 Million Holdings in UiPath, Inc. $PATH

Armistice Capital LLC increased its holdings in shares of UiPath, Inc. (NYSE:PATH - Free Report) by 220.3% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,799,689 shares of the company's stock after buying an additional 1,237,782 shares during the quarter. Armistice Capital LLC owned 0.33% of UiPath worth $18,537,000 as of its most recent SEC filing.

• 3 Robotics Stocks at the Heart of the Robotics Revolution

Other hedge funds have also added to or reduced their stakes in the company. Versant Capital Management Inc raised its stake in shares of UiPath by 198.6% in the 1st quarter. Versant Capital Management Inc now owns 2,962 shares of the company's stock valued at $31,000 after purchasing an additional 1,970 shares during the period. CX Institutional acquired a new stake in shares of UiPath in the 1st quarter valued at about $36,000. Brooklyn Investment Group raised its stake in shares of UiPath by 314.3% in the 1st quarter. Brooklyn Investment Group now owns 4,508 shares of the company's stock valued at $46,000 after purchasing an additional 3,420 shares during the period. National Bank of Canada FI acquired a new stake in shares of UiPath in the 1st quarter valued at about $72,000. Finally, MRP Capital Investments LLC acquired a new stake in shares of UiPath in the 1st quarter valued at about $82,000. Institutional investors and hedge funds own 62.50% of the company's stock.

Insider Transactions at UiPath

In related news, CEO Daniel Dines sold 45,000 shares of UiPath stock in a transaction dated Wednesday, July 16th. The stock was sold at an average price of $12.43, for a total transaction of $559,350.00. Following the completion of the transaction, the chief executive officer owned 5,058,376 shares in the company, valued at approximately $62,875,613.68. This trade represents a 0.88% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Ashim Gupta sold 56,322 shares of UiPath stock in a transaction dated Wednesday, July 2nd. The stock was sold at an average price of $12.72, for a total value of $716,415.84. Following the transaction, the chief financial officer owned 859,991 shares of the company's stock, valued at $10,939,085.52. The trade was a 6.15% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 831,310 shares of company stock valued at $10,428,922 in the last quarter. 23.19% of the stock is currently owned by corporate insiders.

UiPath Stock Performance

• 3 Mid-Cap Stocks Turning Heads in AI, Automation, & Cybersecurity

UiPath stock opened at $11.12 on Friday. UiPath, Inc. has a 52 week low of $9.38 and a 52 week high of $15.93. The stock has a market capitalization of $5.95 billion, a P/E ratio of -92.66, a PEG ratio of 14.57 and a beta of 1.03. The stock has a 50-day simple moving average of $11.91 and a 200 day simple moving average of $11.95.

UiPath (NYSE:PATH - Get Free Report) last posted its quarterly earnings results on Thursday, May 29th. The company reported $0.11 EPS for the quarter, topping analysts' consensus estimates of $0.10 by $0.01. UiPath had a negative return on equity of 3.05% and a negative net margin of 4.65%.The business had revenue of $356.62 million during the quarter, compared to analysts' expectations of $332.17 million. During the same quarter last year, the company posted $0.13 earnings per share. UiPath's quarterly revenue was up 6.4% on a year-over-year basis. Research analysts forecast that UiPath, Inc. will post -0.17 earnings per share for the current year.

Analysts Set New Price Targets

• Top 3 High-Risk, High-Reward Plays for Bullish Investors

PATH has been the topic of several recent research reports. Morgan Stanley lifted their price target on UiPath from $12.00 to $15.00 and gave the company an "equal weight" rating in a research note on Monday, June 2nd. BMO Capital Markets lifted their price target on UiPath from $11.50 to $15.50 and gave the company a "market perform" rating in a research note on Friday, May 30th. Canaccord Genuity Group set a $16.00 price objective on UiPath and gave the company a "buy" rating in a report on Monday, June 2nd. Scotiabank raised their price objective on UiPath from $12.00 to $13.00 and gave the company a "sector perform" rating in a report on Friday, May 30th. Finally, Truist Financial raised their price objective on UiPath from $12.00 to $13.00 and gave the company a "hold" rating in a report on Friday, May 30th. Two equities research analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, UiPath has a consensus rating of "Hold" and a consensus target price of $13.83.

Check Out Our Latest Research Report on UiPath

UiPath Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

Read More

• Five stocks we like better than UiPath
• How to Choose Top Rated Stocks
• DICKS’s Sporting Goods Stock Dropped After Earnings—Is It a Buy?
• Where to Find Earnings Call Transcripts
• Engines to AI: Cummins’ Surprising Growth Driver
• Options Trading - Understanding Strike Price
• Smaller Industrials Names Seeing Surging Growth: Here's Why

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in UiPath Right Now?

Before you consider UiPath, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.

While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here